Table 59Changes in lipid parameters (mean change from baseline, mg/dL)

Hollander, 2009
S2.5/TZDS5/TZDPBO/TZD
Total cholesterol−3.1+0.8−4.3
HDL−1.20−0.4
LDL+1.2+4.3−1.2
TG−13.3−27.4−12.4

Abbreviations: S2.5/5, sitagliptin 2.5/5 mg; PBO, placebo; TZD, thiazolidinedione; HDL, high density lipoprotein; LDL, low density lipoprotein; TG, triglycerides.

From: Results

Cover of Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations
Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report [Internet].
Jonas D, Van Scoyoc E, Gerrald K, et al.
Portland (OR): Oregon Health & Science University; 2011 Feb.
Copyright © 2011, Oregon Health & Science University.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.